PMC5564394

PCR testing for C. difficile detected more than twice as many positive cases as the toxin test (293 vs 131), but toxin-negative/PCR-positive patients had lower bacterial loads, less inflammation, and

Effect: adverse; PCR detected 2x more C. difficile than toxin test; only 44.7% of PCR-positive were toxin-positive; toxin-/PCR+ patients had outcomes similar

PCR testing for C. difficile detected more than twice as many positive cases as the toxin test (293 vs 131), but toxin-negative/PCR-positive patients had lower bacterial loads, less inflammation, and

Effect: adverse; PCR detected 2x more C. difficile than toxin test; only 44.7% of PCR-positive were toxin-positive; toxin-/PCR+ patients had outcomes similar

PCR testing for C. difficile detected more than twice as many positive cases as the toxin test (293 vs 131), but toxin-negative/PCR-positive patients had lower bacterial loads, less inflammation, and

Effect: adverse; PCR detected 2x more C. difficile than toxin test; only 44.7% of PCR-positive were toxin-positive; toxin-/PCR+ patients had outcomes similar

PCR testing for C. difficile detected more than twice as many positive cases as the toxin test (293 vs 131), but toxin-negative/PCR-positive patients had lower bacterial loads, less inflammation, and

Effect: adverse; PCR detected 2x more C. difficile than toxin test; only 44.7% of PCR-positive were toxin-positive; toxin-/PCR+ patients had outcomes similar

PCR testing for C. difficile detected more than twice as many positive cases as the toxin test (293 vs 131), but toxin-negative/PCR-positive patients had lower bacterial loads, less inflammation, and

Effect: adverse; PCR detected 2x more C. difficile than toxin test; only 44.7% of PCR-positive were toxin-positive; toxin-/PCR+ patients had outcomes similar

PCR testing for C. difficile detected more than twice as many positive cases as the toxin test (293 vs 131), but toxin-negative/PCR-positive patients had lower bacterial loads, less inflammation, and

Effect: adverse; PCR detected 2x more C. difficile than toxin test; only 44.7% of PCR-positive were toxin-positive; toxin-/PCR+ patients had outcomes similar

PCR testing for C. difficile detected more than twice as many positive cases as the toxin test (293 vs 131), but toxin-negative/PCR-positive patients had lower bacterial loads, less inflammation, and

Effect: adverse; PCR detected 2x more C. difficile than toxin test; only 44.7% of PCR-positive were toxin-positive; toxin-/PCR+ patients had outcomes similar

PCR testing for C. difficile detected more than twice as many positive cases as the toxin test (293 vs 131), but toxin-negative/PCR-positive patients had lower bacterial loads, less inflammation, and

Effect: adverse; PCR detected 2x more C. difficile than toxin test; only 44.7% of PCR-positive were toxin-positive; toxin-/PCR+ patients had outcomes similar

PCR testing for C. difficile detected more than twice as many positive cases as the toxin test (293 vs 131), but toxin-negative/PCR-positive patients had lower bacterial loads, less inflammation, and

Effect: adverse; PCR detected 2x more C. difficile than toxin test; only 44.7% of PCR-positive were toxin-positive; toxin-/PCR+ patients had outcomes similar

PCR testing for C. difficile detected more than twice as many positive cases as the toxin test (293 vs 131), but toxin-negative/PCR-positive patients had lower bacterial loads, less inflammation, and

Effect: adverse; PCR detected 2x more C. difficile than toxin test; only 44.7% of PCR-positive were toxin-positive; toxin-/PCR+ patients had outcomes similar

PCR testing for C. difficile detected more than twice as many positive cases as the toxin test (293 vs 131), but toxin-negative/PCR-positive patients had lower bacterial loads, less inflammation, and

Effect: adverse; PCR detected 2x more C. difficile than toxin test; only 44.7% of PCR-positive were toxin-positive; toxin-/PCR+ patients had outcomes similar

PCR testing for C. difficile detected more than twice as many positive cases as the toxin test (293 vs 131), but toxin-negative/PCR-positive patients had lower bacterial loads, less inflammation, and

Effect: adverse; PCR detected 2x more C. difficile than toxin test; only 44.7% of PCR-positive were toxin-positive; toxin-/PCR+ patients had outcomes similar

PCR testing for C. difficile detected more than twice as many positive cases as the toxin test (293 vs 131), but toxin-negative/PCR-positive patients had lower bacterial loads, less inflammation, and

Effect: adverse; PCR detected 2x more C. difficile than toxin test; only 44.7% of PCR-positive were toxin-positive; toxin-/PCR+ patients had outcomes similar

PCR testing for C. difficile detected more than twice as many positive cases as the toxin test (293 vs 131), but toxin-negative/PCR-positive patients had lower bacterial loads, less inflammation, and

Effect: adverse; PCR detected 2x more C. difficile than toxin test; only 44.7% of PCR-positive were toxin-positive; toxin-/PCR+ patients had outcomes similar

PCR testing for C. difficile detected more than twice as many positive cases as the toxin test (293 vs 131), but toxin-negative/PCR-positive patients had lower bacterial loads, less inflammation, and

Effect: adverse; PCR detected 2x more C. difficile than toxin test; only 44.7% of PCR-positive were toxin-positive; toxin-/PCR+ patients had outcomes similar

PCR testing for C. difficile detected more than twice as many positive cases as the toxin test (293 vs 131), but toxin-negative/PCR-positive patients had lower bacterial loads, less inflammation, and

Effect: adverse; PCR detected 2x more C. difficile than toxin test; only 44.7% of PCR-positive were toxin-positive; toxin-/PCR+ patients had outcomes similar

PCR testing for C. difficile detected more than twice as many positive cases as the toxin test (293 vs 131), but toxin-negative/PCR-positive patients had lower bacterial loads, less inflammation, and

Effect: adverse; PCR detected 2x more C. difficile than toxin test; only 44.7% of PCR-positive were toxin-positive; toxin-/PCR+ patients had outcomes similar

PCR testing for C. difficile detected more than twice as many positive cases as the toxin test (293 vs 131), but toxin-negative/PCR-positive patients had lower bacterial loads, less inflammation, and

Effect: adverse; PCR detected 2x more C. difficile than toxin test; only 44.7% of PCR-positive were toxin-positive; toxin-/PCR+ patients had outcomes similar

PCR testing for C. difficile detected more than twice as many positive cases as the toxin test (293 vs 131), but toxin-negative/PCR-positive patients had lower bacterial loads, less inflammation, and

Effect: adverse; PCR detected 2x more C. difficile than toxin test; only 44.7% of PCR-positive were toxin-positive; toxin-/PCR+ patients had outcomes similar

PCR testing for C. difficile detected more than twice as many positive cases as the toxin test (293 vs 131), but toxin-negative/PCR-positive patients had lower bacterial loads, less inflammation, and

Effect: adverse; PCR detected 2x more C. difficile than toxin test; only 44.7% of PCR-positive were toxin-positive; toxin-/PCR+ patients had outcomes similar

PCR testing for C. difficile detected more than twice as many positive cases as the toxin test (293 vs 131), but toxin-negative/PCR-positive patients had lower bacterial loads, less inflammation, and

Effect: adverse; PCR detected 2x more C. difficile than toxin test; only 44.7% of PCR-positive were toxin-positive; toxin-/PCR+ patients had outcomes similar

PCR testing for C. difficile detected more than twice as many positive cases as the toxin test (293 vs 131), but toxin-negative/PCR-positive patients had lower bacterial loads, less inflammation, and

Effect: adverse; PCR detected 2x more C. difficile than toxin test; only 44.7% of PCR-positive were toxin-positive; toxin-/PCR+ patients had outcomes similar

PCR testing for C. difficile detected more than twice as many positive cases as the toxin test (293 vs 131), but toxin-negative/PCR-positive patients had lower bacterial loads, less inflammation, and

Effect: adverse; PCR detected 2x more C. difficile than toxin test; only 44.7% of PCR-positive were toxin-positive; toxin-/PCR+ patients had outcomes similar

PCR testing for C. difficile detected more than twice as many positive cases as the toxin test (293 vs 131), but toxin-negative/PCR-positive patients had lower bacterial loads, less inflammation, and

Effect: adverse; PCR detected 2x more C. difficile than toxin test; only 44.7% of PCR-positive were toxin-positive; toxin-/PCR+ patients had outcomes similar

PCR testing for C. difficile detected more than twice as many positive cases as the toxin test (293 vs 131), but toxin-negative/PCR-positive patients had lower bacterial loads, less inflammation, and

Effect: adverse; PCR detected 2x more C. difficile than toxin test; only 44.7% of PCR-positive were toxin-positive; toxin-/PCR+ patients had outcomes similar

PCR testing for C. difficile detected more than twice as many positive cases as the toxin test (293 vs 131), but toxin-negative/PCR-positive patients had lower bacterial loads, less inflammation, and

Effect: adverse; PCR detected 2x more C. difficile than toxin test; only 44.7% of PCR-positive were toxin-positive; toxin-/PCR+ patients had outcomes similar

PCR testing for C. difficile detected more than twice as many positive cases as the toxin test (293 vs 131), but toxin-negative/PCR-positive patients had lower bacterial loads, less inflammation, and

Effect: adverse; PCR detected 2x more C. difficile than toxin test; only 44.7% of PCR-positive were toxin-positive; toxin-/PCR+ patients had outcomes similar

Among 111,631 men receiving new testosterone prescriptions, only 5.4% had androgen deficiency properly diagnosed by two low morning testosterone levels, 16.5% had no testosterone levels checked, nearl

Effect: adverse; Only 5.4% had proper diagnosis; 16.5% had no testosterone levels checked; ~13% had relative contraindications; 1.4% had absolute contraindica

Among 111,631 men receiving new testosterone prescriptions, only 5.4% had androgen deficiency properly diagnosed by two low morning testosterone levels, 16.5% had no testosterone levels checked, nearl

Effect: adverse; Only 5.4% had proper diagnosis; 16.5% had no testosterone levels checked; ~13% had relative contraindications; 1.4% had absolute contraindica

Among 111,631 men receiving new testosterone prescriptions, only 5.4% had androgen deficiency properly diagnosed by two low morning testosterone levels, 16.5% had no testosterone levels checked, nearl

Effect: adverse; Only 5.4% had proper diagnosis; 16.5% had no testosterone levels checked; ~13% had relative contraindications; 1.4% had absolute contraindica

Among 111,631 men receiving new testosterone prescriptions, only 5.4% had androgen deficiency properly diagnosed by two low morning testosterone levels, 16.5% had no testosterone levels checked, nearl

Effect: adverse; Only 5.4% had proper diagnosis; 16.5% had no testosterone levels checked; ~13% had relative contraindications; 1.4% had absolute contraindica

Among 111,631 men receiving new testosterone prescriptions, only 5.4% had androgen deficiency properly diagnosed by two low morning testosterone levels, 16.5% had no testosterone levels checked, nearl

Effect: adverse; Only 5.4% had proper diagnosis; 16.5% had no testosterone levels checked; ~13% had relative contraindications; 1.4% had absolute contraindica

Among 111,631 men receiving new testosterone prescriptions, only 5.4% had androgen deficiency properly diagnosed by two low morning testosterone levels, 16.5% had no testosterone levels checked, nearl

Effect: adverse; Only 5.4% had proper diagnosis; 16.5% had no testosterone levels checked; ~13% had relative contraindications; 1.4% had absolute contraindica

Among 111,631 men receiving new testosterone prescriptions, only 5.4% had androgen deficiency properly diagnosed by two low morning testosterone levels, 16.5% had no testosterone levels checked, nearl

Effect: adverse; Only 5.4% had proper diagnosis; 16.5% had no testosterone levels checked; ~13% had relative contraindications; 1.4% had absolute contraindica

Among 111,631 men receiving new testosterone prescriptions, only 5.4% had androgen deficiency properly diagnosed by two low morning testosterone levels, 16.5% had no testosterone levels checked, nearl

Effect: adverse; Only 5.4% had proper diagnosis; 16.5% had no testosterone levels checked; ~13% had relative contraindications; 1.4% had absolute contraindica

Among 111,631 men receiving new testosterone prescriptions, only 5.4% had androgen deficiency properly diagnosed by two low morning testosterone levels, 16.5% had no testosterone levels checked, nearl

Effect: adverse; Only 5.4% had proper diagnosis; 16.5% had no testosterone levels checked; ~13% had relative contraindications; 1.4% had absolute contraindica

Among 111,631 men receiving new testosterone prescriptions, only 5.4% had androgen deficiency properly diagnosed by two low morning testosterone levels, 16.5% had no testosterone levels checked, nearl

Effect: adverse; Only 5.4% had proper diagnosis; 16.5% had no testosterone levels checked; ~13% had relative contraindications; 1.4% had absolute contraindica

Among 111,631 men receiving new testosterone prescriptions, only 5.4% had androgen deficiency properly diagnosed by two low morning testosterone levels, 16.5% had no testosterone levels checked, nearl

Effect: adverse; Only 5.4% had proper diagnosis; 16.5% had no testosterone levels checked; ~13% had relative contraindications; 1.4% had absolute contraindica

Among 111,631 men receiving new testosterone prescriptions, only 5.4% had androgen deficiency properly diagnosed by two low morning testosterone levels, 16.5% had no testosterone levels checked, nearl

Effect: adverse; Only 5.4% had proper diagnosis; 16.5% had no testosterone levels checked; ~13% had relative contraindications; 1.4% had absolute contraindica

Among 111,631 men receiving new testosterone prescriptions, only 5.4% had androgen deficiency properly diagnosed by two low morning testosterone levels, 16.5% had no testosterone levels checked, nearl

Effect: adverse; Only 5.4% had proper diagnosis; 16.5% had no testosterone levels checked; ~13% had relative contraindications; 1.4% had absolute contraindica

Among 111,631 men receiving new testosterone prescriptions, only 5.4% had androgen deficiency properly diagnosed by two low morning testosterone levels, 16.5% had no testosterone levels checked, nearl

Effect: adverse; Only 5.4% had proper diagnosis; 16.5% had no testosterone levels checked; ~13% had relative contraindications; 1.4% had absolute contraindica

Among 111,631 men receiving new testosterone prescriptions, only 5.4% had androgen deficiency properly diagnosed by two low morning testosterone levels, 16.5% had no testosterone levels checked, nearl

Effect: adverse; Only 5.4% had proper diagnosis; 16.5% had no testosterone levels checked; ~13% had relative contraindications; 1.4% had absolute contraindica

Among 111,631 men receiving new testosterone prescriptions, only 5.4% had androgen deficiency properly diagnosed by two low morning testosterone levels, 16.5% had no testosterone levels checked, nearl

Effect: adverse; Only 5.4% had proper diagnosis; 16.5% had no testosterone levels checked; ~13% had relative contraindications; 1.4% had absolute contraindica

Among 111,631 men receiving new testosterone prescriptions, only 5.4% had androgen deficiency properly diagnosed by two low morning testosterone levels, 16.5% had no testosterone levels checked, nearl

Effect: adverse; Only 5.4% had proper diagnosis; 16.5% had no testosterone levels checked; ~13% had relative contraindications; 1.4% had absolute contraindica

Among 111,631 men receiving new testosterone prescriptions, only 5.4% had androgen deficiency properly diagnosed by two low morning testosterone levels, 16.5% had no testosterone levels checked, nearl

Effect: adverse; Only 5.4% had proper diagnosis; 16.5% had no testosterone levels checked; ~13% had relative contraindications; 1.4% had absolute contraindica

Among 111,631 men receiving new testosterone prescriptions, only 5.4% had androgen deficiency properly diagnosed by two low morning testosterone levels, 16.5% had no testosterone levels checked, nearl

Effect: adverse; Only 5.4% had proper diagnosis; 16.5% had no testosterone levels checked; ~13% had relative contraindications; 1.4% had absolute contraindica

Among 111,631 men receiving new testosterone prescriptions, only 5.4% had androgen deficiency properly diagnosed by two low morning testosterone levels, 16.5% had no testosterone levels checked, nearl

Effect: adverse; Only 5.4% had proper diagnosis; 16.5% had no testosterone levels checked; ~13% had relative contraindications; 1.4% had absolute contraindica

Among 111,631 men receiving new testosterone prescriptions, only 5.4% had androgen deficiency properly diagnosed by two low morning testosterone levels, 16.5% had no testosterone levels checked, nearl

Effect: adverse; Only 5.4% had proper diagnosis; 16.5% had no testosterone levels checked; ~13% had relative contraindications; 1.4% had absolute contraindica

Among 111,631 men receiving new testosterone prescriptions, only 5.4% had androgen deficiency properly diagnosed by two low morning testosterone levels, 16.5% had no testosterone levels checked, nearl

Effect: adverse; Only 5.4% had proper diagnosis; 16.5% had no testosterone levels checked; ~13% had relative contraindications; 1.4% had absolute contraindica

Among 111,631 men receiving new testosterone prescriptions, only 5.4% had androgen deficiency properly diagnosed by two low morning testosterone levels, 16.5% had no testosterone levels checked, nearl

Effect: adverse; Only 5.4% had proper diagnosis; 16.5% had no testosterone levels checked; ~13% had relative contraindications; 1.4% had absolute contraindica